KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
KYTH was delisted on the 30th of September, 2015.
83 hedge funds and large institutions have $464M invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2013 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 14 reducing their positions, and 4 closing their positions.
450% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 4
143% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 14
101% more capital invested
Capital invested by funds: $231M → $464M (+$233M)
28% more funds holding
Funds holding: 65 → 83 (+18)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$12.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.66M |
| 3 |
CCI
Columbus Circle Investors
|
+$7.01M |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$6.97M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$6.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$10.4M |
| 2 |
BCM
BBT Capital Management
Fort Worth,
Texas
|
-$4.82M |
| 3 |
IA
Investor AB
Stockholm,
Sweden
|
-$2.84M |
| 4 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
-$2.71M |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$899K |
KYTH Hedge Fund Activity: Q3 2013 in Review
83 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q3 2013, worth a combined $464M — up 101% from $231M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new KYTH positions and 4 closed out — a net gain of 18 holders — while 34 added to existing stakes and 14 trimmed.
The largest buyer was Waddell & Reed Financial, opening a new position worth an estimated $12.7M. The largest seller was PFM Health Sciences, cutting an estimated $10.4M.
- 83 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q3 2013, up from 65 in Q2 2013.
- Funds reported $464M of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q3 2013, up 101% quarter-over-quarter.
- 22 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q3 2013 and 4 closed out, a net change of +18 holders.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM buyer in Q3 2013 was Waddell & Reed Financial, an estimated $12.7M added.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q3 2013 was PFM Health Sciences, an estimated $10.4M sold.
Based on aggregated 13F filings for Q3 2013.